mRNA Decay analysis in Drosophila melanogaster drug-induced changes in glutathione S-transferase D21 mRNA stability

Bünyamin Akgül1, Chen-Pei D Tu

  • 1Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, Pennsylvania, USA.

Methods in Enzymology
|December 30, 2008
PubMed

Insights

Pentobarbital (PB) affects gene expression by altering messenger RNA (mRNA) decay rates in Drosophila. A specific DNA sequence in the gstD21 mRNA

Area of Science:

  • Molecular Biology
  • Genetics
  • Pharmacology

Background:

  • Pentobarbital (PB) is a psychoactive drug known for its sedative effects.
  • Understanding how drugs influence gene expression at the mRNA level is crucial.
  • The gstD21 gene encodes a Drosophila glutathione S-transferase, an enzyme involved in detoxification.

Purpose of the Study:

  • To establish an in vivo system in Drosophila to investigate the mechanisms of pentobarbital's effect on mRNA decay.
  • To determine the half-life of gstD21 mRNA in response to pentobarbital exposure.
  • To identify specific DNA sequences responsible for pentobarbital-mediated mRNA stabilization.

Main Methods:

  • Utilized hsp70 promoter-based transgenes and transgenic Drosophila lines.
  • Quantified mRNA half-lives using RNase protection assays.
  • Identified and mapped mRNA decay intermediates via complementary RNA-polymerase chain reaction (cRT-PCR) and DNA sequencing.

Main Results:

  • Developed a robust in vivo system for studying mRNA decay in Drosophila.
  • Demonstrated that pentobarbital significantly alters the decay rate of gstD21 mRNA.
  • Localized the pentobarbital-responsive cis-acting element to a 59-nucleotide sequence within the 3'-untranslated region (3'-UTR) of gstD21 mRNA.

Conclusions:

  • The 3'-UTR of gstD21 mRNA plays a critical role in regulating mRNA decay in response to pentobarbital.
  • A specific cis-acting element within the 3'-UTR mediates pentobarbital-induced stabilization of gstD21 mRNA.
  • This study provides insights into the molecular mechanisms underlying the pharmacogenetic effects of pentobarbital on gene expression.